BLAUVELT, A.; PAPP, K. A.; MEROLA, J. F.; GOTTLIEB, A. B.; CROSS, N.; MADDEN, C.; PETERSON, L.; CIOFFI, C.; GRIFFITHS, C. E. Bimekizumab provides rapid and sustained improvements in scalp and nail outcomes in patients with moderate to severe plaque psoriasis: 60 week results from a randomized, double blinded, Phase 2b extension study. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 3, p. S34, 2019. DOI: 10.25251/skin.3.supp.34. Disponível em: Acesso em: 2 dec. 2023.